Jingxia Chang

538 total citations
20 papers, 434 citations indexed

About

Jingxia Chang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jingxia Chang has authored 20 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jingxia Chang's work include MicroRNA in disease regulation (6 papers), Cell Adhesion Molecules Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jingxia Chang is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cell Adhesion Molecules Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jingxia Chang collaborates with scholars based in China and United States. Jingxia Chang's co-authors include Guojun Zhang, Huaqi Wang, Guoqiang Zhao, Li‐Li Lou, Feng Gao, Heying Chu, Mengyuan Tian, Fangfang Li, Ping Li and Feng Gao and has published in prestigious journals such as Frontiers in Immunology, Journal of Cellular Physiology and Biomedicine & Pharmacotherapy.

In The Last Decade

Jingxia Chang

18 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingxia Chang China 10 316 245 119 45 35 20 434
Gallina Kazobinka China 11 311 1.0× 148 0.6× 77 0.6× 87 1.9× 23 0.7× 20 405
Siwen Dang China 7 408 1.3× 211 0.9× 64 0.5× 70 1.6× 25 0.7× 8 524
Sampa Ghose India 12 185 0.6× 99 0.4× 52 0.4× 67 1.5× 42 1.2× 20 344
Kunming Wen China 13 287 0.9× 151 0.6× 70 0.6× 136 3.0× 32 0.9× 29 417
Junxia Gu China 13 251 0.8× 99 0.4× 35 0.3× 74 1.6× 25 0.7× 35 392
Xu Shi China 12 146 0.5× 153 0.6× 165 1.4× 58 1.3× 44 1.3× 24 316
Min Cheng China 10 218 0.7× 209 0.9× 54 0.5× 47 1.0× 19 0.5× 19 326
Saibyasachi N. Choudhury United States 7 270 0.9× 254 1.0× 25 0.2× 44 1.0× 43 1.2× 7 404
Shiyong Xin China 11 271 0.9× 232 0.9× 104 0.9× 51 1.1× 32 0.9× 30 382

Countries citing papers authored by Jingxia Chang

Since Specialization
Citations

This map shows the geographic impact of Jingxia Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxia Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxia Chang more than expected).

Fields of papers citing papers by Jingxia Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxia Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxia Chang. The network helps show where Jingxia Chang may publish in the future.

Co-authorship network of co-authors of Jingxia Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxia Chang. A scholar is included among the top collaborators of Jingxia Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxia Chang. Jingxia Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chang, Jingxia, Meng Zhang, Li‐Li Lou, Heying Chu, & Huaqi Wang. (2024). KIS, a target of SOX4, regulates the ID1-mediated enhancement of β-catenin to facilitate lung adenocarcinoma cell proliferation and metastasis. Journal of Cancer Research and Clinical Oncology. 150(7). 366–366.
3.
Zhu, Runzhi, Jingxia Chang, Haixia Xu, et al.. (2021). The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers. Frontiers in Oncology. 11. 691199–691199. 9 indexed citations
4.
Chang, Jingxia, Li‐Li Lou, Heying Chu, et al.. (2020). Xanthatin alleviates airway inflammation in asthmatic mice by regulating the STAT3/NF-κB signaling pathway. Respiratory Physiology & Neurobiology. 281. 103491–103491. 6 indexed citations
5.
Chu, Heying, et al.. (2019). MicroRNA-206 promotes lipopolysaccharide-induced inflammation injury via regulation of IRAK1 in MRC-5 cells. International Immunopharmacology. 73. 590–598. 15 indexed citations
6.
Lou, Li‐Li, Mengyuan Tian, Jingxia Chang, Fangfang Li, & Guojun Zhang. (2019). MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomedicine & Pharmacotherapy. 122. 109692–109692. 77 indexed citations
7.
Chang, Jingxia, Feng Gao, Heying Chu, et al.. (2019). miR‐363‐3p inhibits migration, invasion, and epithelial–mesenchymal transition by targeting NEDD9 and SOX4 in non‐small‐cell lung cancer. Journal of Cellular Physiology. 235(2). 1808–1820. 42 indexed citations
8.
Chang, Jingxia, Feng Gao, Guoqiang Zhao, & Guojun Zhang. (2014). Effects of lentivirus-mediated RNAi knockdown of NEDD9 on human lung adenocarcinoma cells in vitro and in vivo. Oncology Reports. 32(4). 1543–1549. 6 indexed citations
10.
Li, Ping, Juan Li, Tengfei Chen, et al.. (2014). Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. International Journal of Molecular Medicine. 33(6). 1554–1562. 52 indexed citations
11.
Gao, Feng, Jingxia Chang, Huaqi Wang, & Guojun Zhang. (2013). Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients. Oncology Reports. 31(1). 351–357. 55 indexed citations
12.
Li, Ping, Guoqiang Zhao, Tengfei Chen, et al.. (2013). Serum miR-21 and miR-155 expression in idiopathic pulmonary fibrosis. Journal of Asthma. 50(9). 960–964. 48 indexed citations
13.
Chu, Heying, Xudong Chen, Huaqi Wang, et al.. (2013). MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3. Tumor Biology. 35(4). 3487–3494. 46 indexed citations
14.
Chang, Jingxia, Huaqi Wang, Guoqiang Zhao, Heying Chu, & Guojun Zhang. (2012). Construction and characterization of a eukaryotic expression vector for small interfering RNA targeting the NEDD9 gene. International Journal of Molecular Medicine. 30(6). 1343–1348. 2 indexed citations
15.
Chang, Jingxia, et al.. (2012). Regulation of neutrophil gelatinase-associated lipocalin expression by C/EBPβ in lung carcinoma cells. Oncology Letters. 4(5). 919–924. 2 indexed citations
16.
Chang, Jingxia, Feng Gao, Guoqiang Zhao, & Guojun Zhang. (2012). Role of NEDD9 in invasion and metastasis of lung adenocarcinoma. Experimental and Therapeutic Medicine. 4(5). 795–800. 18 indexed citations
17.
Chang, Jingxia, Feng Gao, Guoqiang Zhao, & Guojun Zhang. (2012). Expression and clinical significance of NEDD9 in lung tissues. Medical Oncology. 29(4). 2654–2660. 32 indexed citations
18.
Du, Zepeng, Bingli Wu, Jingxia Chang, et al.. (2011). Neutrophil gelatinase-associated lipocalin in gastric carcinoma cells and its induction by TPA are controlled by C/EBPβ. Biochemistry and Cell Biology. 89(3). 314–324. 15 indexed citations
19.
Xu, Li‐Yan, En‐Min Li, Yongdong Niu, et al.. (2006). There are TPA response elements in --152--- --60 position of {\sl NGAL} gene 5' flanking region in the esophageal cancer cells EC109. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 33(2). 140–148. 3 indexed citations
20.
Qin, Tao, et al.. (1998). [Studies on multiple infection with hepatitis B, C and G viruses].. PubMed. 32(1). 13–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026